Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion
暂无分享,去创建一个
[1] A. Giordano,et al. Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas , 2020, Cancer biology & therapy.
[2] A. Giordano,et al. Multifaceted Breast Cancer: The Molecular Connection With Obesity , 2017, Journal of cellular physiology.
[3] A. Giordano,et al. Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects? , 2016, Journal of cellular physiology.
[4] E. Rendina,et al. Cardiosphere Conditioned Media Influence the Plasticity of Human Mediastinal Adipose Tissue-Derived Mesenchymal Stem Cells , 2015, Cell transplantation.
[5] Isotta Chimenti,et al. The Potential of GMP-Compliant Platelet Lysate to Induce a Permissive State for Cardiovascular Transdifferentiation in Human Mediastinal Adipose Tissue-Derived Mesenchymal Stem Cells , 2015, BioMed research international.
[6] W. Woodward,et al. Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells , 2015, PloS one.
[7] A. Fiorelli,et al. Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis. , 2015, The Annals of thoracic surgery.
[8] G. Pirozzi,et al. Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma , 2015, Oncoscience.
[9] A. Giordano,et al. pRb2/p130 Localizes to the Cytoplasm in Diffuse Gastric Cancer , 2015, Journal of cellular physiology.
[10] C. Murdoch,et al. Stem Cell Therapies for Ischemic Cardiovascular Diseases , 2015 .
[11] A. Porcellini,et al. The p85 Regulatory Subunit of PI3K Mediates cAMP-PKA and Insulin Biological Effects on MCF-7 Cell Growth and Motility , 2014, TheScientificWorldJournal.
[12] D. Balciunas,et al. Extreme Thermal Noxious Stimuli Induce Pain Responses in Zebrafish Larvae , 2014, Journal of cellular physiology.
[13] R. Franco,et al. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage. , 2014, Current cancer drug targets.
[14] G. Tse,et al. P-cadherin and vimentin are useful basal markers in breast cancers. , 2013, Human pathology.
[15] R. Franco,et al. Prognostic implications of node metastatic features in OSCC: a retrospective study on 121 neck dissections. , 2013, Oncology reports.
[16] H. Lee,et al. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer. , 2013, Human pathology.
[17] R. Ralhan,et al. Clinical Significance of Altered Expression of β-Catenin and E-Cadherin in Oral Dysplasia and Cancer: Potential Link with ALCAM Expression , 2013, PloS one.
[18] R. Franco,et al. BRAF mutation and RASSF1A expression in thyroid carcinoma of southern Italy , 2013, Journal of Cellular Biochemistry.
[19] P. Erne,et al. Cross-talk between EGFR and T-cadherin: EGFR activation promotes T-cadherin localization to intercellular contacts. , 2013, Cellular signalling.
[20] D. Fernig,et al. Analysis of the fibroblast growth factor receptor (FGFR) signalling network with heparin as coreceptor: evidence for the expansion of the core FGFR signalling network , 2013, The FEBS journal.
[21] S. Ceccarelli,et al. TNFα Modulates Fibroblast Growth Factor Receptor 2 Gene Expression through the pRB/E2F1 Pathway: Identification of a Non-Canonical E2F Binding Motif , 2013, PloS one.
[22] A. Fiorelli,et al. The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion. , 2013, Interactive cardiovascular and thoracic surgery.
[23] M. Vered,et al. "Is immuno-expression of E-cadherin really a prognostic factor in head and neck cancer?". , 2013, Oral oncology.
[24] T. Hibi,et al. Mesenchymal stem cells regulate epithelial–mesenchymal transition and tumor progression of pancreatic cancer cells , 2013, Cancer science.
[25] G. Botti,et al. Current treatment of cutaneous squamous cancer and molecular strategies for its sensitization to new target-based drugs , 2013, Expert opinion on biological therapy.
[26] W. Seeger,et al. E-cadherin controls bronchiolar progenitor cells and onset of preneoplastic lesions in mice. , 2012, Neoplasia.
[27] Wendy Frankel,et al. The onco-embryonic antigen ROR1 is expressed by a variety of human cancers. , 2012, The American journal of pathology.
[28] D. Corey,et al. Structure of a Force-Conveying Cadherin Bond Essential for Inner-Ear Mechanotransduction , 2012, Nature.
[29] I. Braña,et al. Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[30] G. Botti,et al. pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma , 2012, Cancer biology & therapy.
[31] L. Perillo,et al. Cytokines and VEGF Induction in Orthodontic Movement in Animal Models , 2012, Journal of biomedicine & biotechnology.
[32] T. Kawabe,et al. Involvement of the transcription factor twist in phenotype alteration through epithelial–mesenchymal transition in lung cancer cells , 2012, Molecular carcinogenesis.
[33] A. Porcellini,et al. The p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration. , 2012, International journal of oncology.
[34] Hanmin Wang,et al. Hypoxia-Induced Down-Regulation of microRNA-34a Promotes EMT by Targeting the Notch Signaling Pathway in Tubular Epithelial Cells , 2012, PloS one.
[35] T. Oskarsson,et al. Extracellular matrix players in metastatic niches , 2012, The EMBO journal.
[36] Moorthy P Ponnusamy,et al. Targeting the EGFR signaling pathway in cancer therapy , 2012, Expert opinion on therapeutic targets.
[37] R Rullo,et al. Prognostic significance of N-Cadherin expression in oral squamous cell carcinoma. , 2011, Anticancer research.
[38] A. Fiorelli,et al. Interplay between steroid receptors and neoplastic progression in sarcoma tumors , 2011, Journal of cellular physiology.
[39] C. Carratelli,et al. Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae. , 2011, Cytokine.
[40] M. Guida,et al. Epigenetic fingerprint in endometrial carcinogenesis: The hypothesis of a uterine field cancerization , 2011, Cancer biology & therapy.
[41] K. Jones,et al. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. , 2011, Cancer research.
[42] J. Morgado-Díaz,et al. Inhibition of N-linked glycosylation by tunicamycin induces E-cadherin-mediated cell–cell adhesion and inhibits cell proliferation in undifferentiated human colon cancer cells , 2011, Cancer Chemotherapy and Pharmacology.
[43] Y. Luqmani,et al. Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition (Review). , 2011, International journal of oncology.
[44] C. Wansleeben,et al. The planar cell polarity pathway in vertebrate development , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.
[45] A. Giordano,et al. Rb family proteins in gastric cancer (review). , 2010, Oncology reports.
[46] Cathrin Brisken,et al. Epithelial‐Mesenchymal Transition‐Derived Cells Exhibit Multilineage Differentiation Potential Similar to Mesenchymal Stem Cells , 2010, Stem cells.
[47] Wei Li,et al. Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway , 2010, Breast Cancer Research.
[48] Zhiwei Wang,et al. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. , 2010, Current drug targets.
[49] Michel Salzet,et al. Epithelial-mesenchymal transition in ovarian cancer. , 2010, Cancer letters.
[50] Harald J. Maier,et al. BI 5700, a Selective Chemical Inhibitor of IκB Kinase 2, Specifically Suppresses Epithelial-Mesenchymal Transition and Metastasis in Mouse Models of Tumor Progression. , 2010, Genes & cancer.
[51] Felice-Alessio Bava,et al. Human colon fibroblasts induce differentiation and proliferation of intestinal epithelial cells through the direct paracrine action of keratinocyte growth factor , 2009, Journal of cellular physiology.
[52] M. Russo,et al. Down‐regulation of epidermal growth factor receptor induced by estrogens and phytoestrogens promotes the differentiation of U2OS human osteosarcoma cells , 2009, Journal of cellular physiology.
[53] S. Alahari,et al. Molecular mechanisms controlling E-cadherin expression in breast cancer. , 2009, Biochemical and biophysical research communications.
[54] Mads Lerdrup,et al. Differential Effects of EGFR Ligands on Endocytic Sorting of the Receptor , 2009, Traffic.
[55] R. Moon,et al. Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis , 2009, Cell Research.
[56] S. Muthuswamy,et al. ErbB receptors and cell polarity: new pathways and paradigms for understanding cell migration and invasion. , 2009, Experimental cell research.
[57] Li-Xuan Qin,et al. gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity. , 2009, Cancer research.
[58] Y. Kanai. Alterations of DNA methylation and clinicopathological diversity of human cancers , 2008, Pathology international.
[59] P. Speight,et al. The relationship between E-cadherin expression, clinical stage and tumour differentiation in oral squamous cell carcinoma. , 2008, Oral diseases.
[60] K. Roepstorff,et al. Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer , 2008, Histochemistry and Cell Biology.
[61] Christopher S. Chen,et al. Rac-dependent cyclin D1 gene expression regulated by cadherin- and integrin-mediated adhesion , 2008, Journal of Cell Science.
[62] Yun Cao,et al. [Expression and significance of E-cadherin in adenoid cystic carcinoma of the salivary glands]. , 2007, Ai zheng = Aizheng = Chinese journal of cancer.
[63] A. Kinsella,et al. Expression of the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck. , 2007, Clinical otolaryngology and allied sciences.
[64] A. Hall,et al. Cdc42 and noncanonical Wnt signal transduction pathways cooperate to promote cell polarity , 2007, The Journal of cell biology.
[65] R. Kalluri,et al. Mechanisms of metastasis: Epithelial‐to‐mesenchymal transition and contribution of tumor microenvironment , 2007, Journal of cellular biochemistry.
[66] M. Ferracin,et al. Regulation of microRNA Expression: the Hypoxic Component , 2007, Cell cycle.
[67] Wenbin Ye,et al. MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia , 2006, PloS one.
[68] S. Bray. Notch signalling: a simple pathway becomes complex , 2006, Nature Reviews Molecular Cell Biology.
[69] Y. Sugimoto,et al. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells. , 2006, Anticancer research.
[70] N. Fukuda,et al. Cardiac progenitor cells in brown adipose tissue repaired damaged myocardium. , 2006, Biochemical and biophysical research communications.
[71] N. Normanno,et al. Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: different mechanisms of action for a novel therapeutic application? , 2006, Endocrine-related cancer.
[72] J. Behrens,et al. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts. , 2006, Experimental cell research.
[73] A. García-García,et al. Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. , 2006, Oral oncology.
[74] C. Stratakis,et al. Serial analysis of gene expression in adrenocortical hyperplasia caused by a germline PRKAR1A mutation. , 2006, The Journal of clinical endocrinology and metabolism.
[75] Y. Doki,et al. Overexpression of ADAM9 enhances growth factor-mediated recycling of E-cadherin in human colon cancer cell line HT29 cells. , 2005, Experimental cell research.
[76] A. Bilancio,et al. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. , 2005, Cancer research.
[77] Alfonso Bellacosa,et al. Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways , 2005, Oncogene.
[78] J. Schlessinger,et al. Epidermal Growth Factor Receptor Dimerization and Activation Require Ligand-Induced Conformational Changes in the Dimer Interface , 2005, Molecular and Cellular Biology.
[79] K. Aldape,et al. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. , 2005, Human pathology.
[80] Thomas Kirchner,et al. Invasion and Metastasis in Colorectal Cancer: Epithelial-Mesenchymal Transition, Mesenchymal-Epithelial Transition, Stem Cells and β-Catenin , 2005, Cells Tissues Organs.
[81] S. Weiss,et al. Wnt-dependent Regulation of the E-cadherin Repressor Snail* , 2005, Journal of Biological Chemistry.
[82] D. Solter,et al. Stabilization of β-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast , 2004, Development.
[83] J. Kutok,et al. Notch Oncoproteins Depend on γ-Secretase/Presenilin Activity for Processing and Function* , 2004, Journal of Biological Chemistry.
[84] R. Tuan,et al. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[85] Salvatore Pece,et al. Endocytosis and cancer. , 2004, Current opinion in cell biology.
[86] Avri Ben-Ze'ev,et al. Autoregulation of E-cadherin expression by cadherin–cadherin interactions , 2003, The Journal of cell biology.
[87] Adrian V. Lee,et al. Estrogen-mediated down-regulation of E-cadherin in breast cancer cells. , 2003, Cancer research.
[88] M. Russo,et al. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER α and β subtypes via an Sp1 site , 2003, Oncogene.
[89] Keith R. Johnson,et al. Characterization of Cadherin-24, a Novel Alternatively Spliced Type II Cadherin* , 2003, Journal of Biological Chemistry.
[90] M. Nagayama,et al. Downregulation of Wnt4 and upregulation of Wnt5a expression by epithelialmesenchymal transition in human squamous carcinoma cells , 2003, Cancer science.
[91] A. Buda,et al. Abnormalities of the cadherin-catenin complex in chemically-induced colo-rectal carcinogenesis , 2003, Proceedings of the Nutrition Society.
[92] J. Baselga,et al. Epithelial growth factor receptor interacting agents. , 2002, Hematology/oncology clinics of North America.
[93] V. Kosma,et al. Reduced expression of α-catenin, β-catenin, and γ-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer , 2001, Journal of clinical pathology.
[94] N. Sampas,et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.
[95] S. Mosselman,et al. Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells. , 2000, Molecular endocrinology.
[96] M. Ilyas. Adhesion molecule expression in breast cancer: the phoenix in tumour metastasis? , 2000, The Journal of pathology.
[97] F. André,et al. Integrins and E‐cadherin cooperate with IGF‐I to induce migration of epithelial colonic cells , 1999, International journal of cancer.
[98] Keith R. Johnson,et al. N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression , 1999, The Journal of cell biology.
[99] M. Hendrix,et al. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. , 1999, Cancer research.
[100] R. Kemler,et al. The C-terminal transactivation domain of β-catenin is necessary and sufficient for signaling by the LEF-1/β-catenin complex in Xenopus laevis , 1999, Mechanisms of Development.
[101] D. McClay,et al. Nuclear beta-catenin is required to specify vegetal cell fates in the sea urchin embryo. , 1999, Development.
[102] M. Quintanilla,et al. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[103] F. Watt,et al. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity , 1998, The Journal of pathology.
[104] A. Børresen-Dale,et al. E‐cadherin and α‐, β‐, and γ‐catenin protein expression in relation to metastasis in human breast carcinoma , 1998 .
[105] C. Larabell,et al. Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.
[106] T. Carey,et al. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion , 1996, The Journal of cell biology.
[107] P. McCrea,et al. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes. , 1996, Cancer research.
[108] M. Monden,et al. Decreased E‐cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus , 1996, The British journal of surgery.
[109] S. Nishizuka,et al. Inactivation of the E‐Cadherin Gene in Primary Gastric Carcinomas and Gastric Carcinoma Cell Lines , 1996, Japanese journal of cancer research : Gann.
[110] Y. Yarden,et al. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor , 1996, Molecular and cellular biology.
[111] A. Bilancio,et al. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. , 1996, Cancer research.
[112] S. Hirohashi,et al. E‐Cadherin Gene Mutations in Signet Ring Cell Carcinoma of the Stomach , 1996, Japanese journal of cancer research : Gann.
[113] R. Yarden,et al. Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells. , 1996, Endocrinology.
[114] M. Takeichi,et al. Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells. , 1995, Oncogene.
[115] S. Minoguchi,et al. Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-Jκ/Su(H) , 1995, Current Biology.
[116] Christel Brou,et al. Signalling downstream of activated mammalian Notch , 1995, Nature.
[117] J. Feramisco,et al. Immunohistochemical evaluation of E-cadherin and epidermal growth factor receptor in non-small cell lung cancer. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[118] J. Spencer,et al. E-cadherin expression in intestinal epithelium. , 1995, Journal of clinical pathology.
[119] N. Lemoine,et al. Loss of membranous E‐cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stage , 1994, The Journal of pathology.
[120] Y. Horiguchi,et al. Cadherins in Cutaneous Biology , 1994, The Journal of dermatology.
[121] S. Nagata,et al. Soluble fragments of e-cadherin cell-adhesion molecule increase in urinary-excretion of cancer-patients, potentially indicating its shedding from epithelial tumor-cells. , 1994, International journal of oncology.
[122] K. Jahnke,et al. E-cadherin as a functional marker of the differentiation and invasiveness of squamous cell carcinoma of the head and neck. , 1994, Clinical otolaryngology and allied sciences.
[123] D. Ruiter,et al. E‐cadherin expression in head and neck squamous‐cell carcinoma is associated with clinical outcome , 1993, International journal of cancer.
[124] R. Poulsom,et al. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. , 1993, The American journal of pathology.
[125] Frans,et al. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene , 1993, The Journal of cell biology.
[126] M. Oka,et al. Immunohistochemical detection of desmosomes in oral squamous cell carcinomas: correlation with differentiation, mode of invasion, and metastatic potential. , 1992, International journal of oral and maxillofacial surgery.
[127] M. Toyota,et al. Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma. , 1992, International journal of oncology.
[128] W. Birchmeier,et al. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. , 1991, Cancer research.
[129] W. Fiers,et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.
[130] P. Goodfellow,et al. Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. , 1988, Differentiation; research in biological diversity.
[131] G. Stancel,et al. Estrogen regulation of epidermal growth factor receptor messenger ribonucleic acid. , 1988, Molecular endocrinology.
[132] S. Cohen,et al. Epidermal growth factor , 1972, The Journal of investigative dermatology.
[133] M. Bennett,et al. EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURS , 1985, The Lancet.
[134] L. Frati,et al. Levels of epidermal growth factor in mice: tissues measured by a specific radioreceptor assay. , 1976, Life sciences.
[135] L. Frati,et al. Selective binding of the epidermal growth factor and its specific effects on the epithelial cells of the cornea. , 1972, Experimental eye research.
[136] L. Frati,et al. The mechanism of action of the epidermal growth factor. 3. Stimulation of the uptake of labeled precursors into RNA, DNA and proteins induced by EGF in isolated tumor cells. , 1972, Hormones.
[137] L. Frati,et al. Synthesis of bioactive 131 I-labeled epidermal growth factor and its distribution in rat tissues. , 1972, European journal of biochemistry.
[138] S. Cohen,et al. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. , 1962, The Journal of biological chemistry.
[139] T. Kang,et al. Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations. , 2014, Drug discovery today.
[140] L. Pierelli,et al. Optimization of the isolation and expansion method of human mediastinal–adipose tissue derived mesenchymal stem cells with virally inactivated GMP-grade platelet lysate , 2013, Cytotechnology.
[141] A. Al Moustafa,et al. EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas. , 2012, Frontiers in bioscience.
[142] S. Corvera,et al. The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells , 2012 .
[143] J. Kutok,et al. Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and function. , 2004, The Journal of biological chemistry.
[144] Frank McCormick,et al. Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. , 2004, Genes & development.
[145] M. Russo,et al. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER alpha and beta subtypes via an Sp1 site. , 2003, Oncogene.
[146] E. Cuppen,et al. The Wnt/beta-catenin pathway regulates cardiac valve formation. , 2003, Nature.
[147] V. Kosma,et al. Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. , 2001, Journal of clinical pathology.
[148] A. Wells,et al. Tumor invasion: role of growth factor-induced cell motility. , 2000, Advances in cancer research.
[149] A. de Bruin,et al. Loss of invasiveness in squamous cell carcinoma cells overexpressing desmosomal cadherins. , 1999, Cell adhesion and communication.
[150] A. Børresen-Dale,et al. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. , 1998, The Journal of pathology.
[151] I. Mackenzie,et al. Rates of clearance of the epithelial surfaces of mouse oral mucosa and skin. , 1994, Epithelial cell biology.
[152] G. Cunha,et al. Stromal regulation of epithelial function. , 1991, Cancer treatment and research.
[153] Atsushi Ochiai,et al. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas. , 1988, Cancer research.